Hi Guest Login
Home > Oncotype Dx Breast Cancer Test > Ghaziabad
Furthermore, it provides valuable insight into: -
The likelihood of cancer metastasizing to other organs in the future.
It helps determine whether combining chemotherapy with hormone therapy could offer additional benefits.
The cost of Oncotype DX cancer test in Ghaziabad ranges between INR 2.5 to 3.5 lakhs, depending on the provider and logistics. Some private health insurance policies may offer partial or full reimbursement. It is advisable to check with your insurance provider in advance.
Even though Oncotype DX is the most well-validated and best-represented genomic test within this category, oncologists might also think about ordering the following tests: MammaPrint – 70-gene signature test to predict risk of breast cancer recurrence. Ki-67 – Protein marker to assess cell proliferation rate. BRCA1/2 or Comprehensive Hereditary Cancer Panel – Particularly for a strong family history of cancer. Yet, Oncotype DX is alone in its prediction of benefit from chemotherapy and is thus the treatment of choice in most eligible situations.
It doesn't apply to HER2-positive or triple-negative breast cancer. It is not suitable for metastatic (Stage IV) breast cancer. It doesn't replace the necessity for conventional staging or receptor testing.
Recurrence Score Result: Indicates your result between 0 and 100.
Estimated Risk of Distant Recurrence: Provides a percentage risk of recurrence of cancer in 9 years if given hormonal therapy alone.
Chemotherapy Benefit Prediction: States whether chemotherapy lowered the risk of recurrence by a great extent.
Recurrence Score | Risk of Recurrence | Chemotherapy Benefit |
0 - 10 | Very Low | Not Beneficial |
11 - 17 | Low | Likely Not Beneficial |
18 - 25 | Intermediate | Benefit Possible, especially in younger patients |
26 - 100 | High | Chemotherapy Recommended |
This score is utilized along with clinical factors such as age, tumor size, and grade to inform treatment decisions.
The information given here is for general purposes only and is not to be used as medical consultation or an alternative to professional advice, diagnosis, or treatment. Always consult your healthcare provider or oncologist to decide the best course of treatment for your specific case.
Read More